Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on Lebrikizumab for Adults with Chronic Rhinosinusitis and Nasal Polyps Using Intranasal Corticosteroids

    Recruiting

    1 1 1
    Belgium Bulgaria Denmark Finland Germany Hungary +5
  • Study on Long-term Safety of Vedolizumab and Prednisone in Children with Ulcerative Colitis or Crohn’s Disease

    Recruiting

    1 1 1 1
    Investigated drugs:
    Belgium Croatia Greece Hungary Italy Poland
  • Study of Pembrolizumab with Drug Combination for Patients with Microsatellite Stable Metastatic Colorectal Cancer with High Immune Infiltrate

    Recruiting

    1 1 1
    France
  • Study on Stopping Prednisolone Early in Patients with Negative FDG-PET/CT and Idiopathic Retroperitoneal Fibrosis

    Recruiting

    1 1 1 1
    Investigated drugs:
    France
  • Study on Nefopam for Reducing Postoperative Pain in Adults After Total Knee Replacement Surgery

    Recruiting

    1 1
    France
  • Study of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Denmark Germany Italy Portugal Sweden
  • Study on the Effects of Ketoprofen and Drug Combination in Patients Undergoing Pleurodesis Surgery for Pneumothorax

    Recruiting

    1 1 1
    Investigated diseases:
    France
  • Study of Mirikizumab for Children with Moderate to Severe Crohn’s Disease

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium France Italy The Netherlands Norway +3
  • Study Comparing Elranatamab, Daratumumab, and Lenalidomide with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

    Recruiting

    1 1 1 1
    Austria Belgium Czechia Denmark Finland France +6
  • Study comparing prophylactic versus selective surfactant (poractant alfa, phospholipid fraction) administration in preterm infants with respiratory distress syndrome aged 25-30 weeks

    Recruiting

    1 1 1 1
    Germany